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Abstract
The herpesvirus proteins HSV-1 ICP27 and HVS ORF57 promote viral mRNA export by utilizing the cellular mRNA export
machinery. This function is triggered by binding to proteins of the transcription-export (TREX) complex, in particular to REF/
Aly which directs viral mRNA to the TAP/NFX1 pathway and, subsequently, to the nuclear pore for export to the cytoplasm.
Here we have determined the structure of the REF-ICP27 interaction interface at atomic-resolution and provided a detailed
comparison of the binding interfaces between ICP27, ORF57 and REF using solution-state NMR. Despite the absence of any
obvious sequence similarity, both viral proteins bind on the same site of the folded RRM domain of REF, via short but
specific recognition sites. The regions of ICP27 and ORF57 involved in binding by REF have been mapped as residues 104–
112 and 103–120, respectively. We have identified the pattern of residues critical for REF/Aly recognition, common to both
ICP27 and ORF57. The importance of the key amino acid residues within these binding sites was confirmed by site-directed
mutagenesis. The functional significance of the ORF57-REF/Aly interaction was also probed using an ex vivo cytoplasmic
viral mRNA accumulation assay and this revealed that mutants that reduce the protein-protein interaction dramatically
decrease the ability of ORF57 to mediate the nuclear export of intronless viral mRNA. Together these data precisely map
amino acid residues responsible for the direct interactions between viral adaptors and cellular REF/Aly and provide the first
molecular details of how herpes viruses access the cellular mRNA export pathway.
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Introduction
All herpesviruses replicate in the host cell nucleus and therefore
utilise the host cell’s protein transcription and translation apparatus,
while at the same time suppressing the correspondent cellular
processes [1–5]. Crucially, non-spliced viral mRNA is directed into
the cellular mRNA export machinery, thus bypassing the stringent
cellular controls which normally ensure that only fully processed
mRNA is exported from the nucleus to the cytoplasm. In an
uninfected cell, the process of mRNA export is closely connected
with mRNA processing and splicing, which in turn are coupled with
transcription. Cellular mRNA export involves the assembly of a
multi-protein transcription and export (TREX) complex containing
the RNA export factor REF/Aly; this signals that processing is
complete and the cellular mRNA is ready to be exported via a
TAP/NXF1-mediated interaction with the nuclear pore [6–8].
TAP forms a heterodimer with p15 and binds nucleoporins via
central and C-terminal UBA-like domains [9]. REF/Aly provides a
crucial link between mRNA and TAP: the binding of mRNA and
TAP to REF are mutually-exclusive. TAP binding to REF-mRNA
complex triggers transfer of RNA from REF to TAP. While REF is
bound, it switches TAP into a high-affinity binding mode for RNA
[10]. Once the ribonucleoprotein complex reaches the nuclear pore,
REF dissociates and the mRNA is transported to the cytoplasm
[11]. It is also possible that other cellular mRNA export factors may
fulfil a role similar to that of REF/Aly [12–14]. Unlike cellular
mRNA, the herpesvirus mRNA is often unspliced, therefore it
cannot acquire export marker proteins using the normal pathway,
via coupled transcription, splicing and export. To facilitate the
efficient export of intronless viral mRNA all herpesviridiae produce
a multi-functional adaptor protein [15] that shuttles between the
nucleus and cytoplasm [3,4,16], and bridges between the viral
mRNA and components of the TREX complex such as REF/Aly,
thus marking viral mRNAs for export via TAP/NFX1 [17,18]. In
Herpes Simplex Virus type I (HSV-1) the infected cell protein 27
(ICP27) acts as the adaptor [3,19]. In Herpesvirus Saimiri (HVS),
the prototype c-2 herpesvirus with close similarity to human
Kaposi’s Sarcoma-associated herpesvirus (KSHV), this role is
carried out by the ORF57 protein [4,20–22].
The regions of ICP27 and ORF57 involved in REF binding
have been studied by analysing the effects of polypeptide
truncations. For ICP27 it has been inferred as amino acids (aa)
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104–138 [19,23]. Recent in vivo studies suggested that the RGG
box aa 138–152, which is involved in viral mRNA binding [2,24–
26], is also involved in REF/Aly interactions [27]. However,
earlier in vitro data indicate that the RGG region does not bind
REF directly [19]. In ORF57 the interactions with REF and with
viral mRNA were localised within aa 8–120 [22,28,29]. Thus the
identified regions of ICP27 and ORF57 apparently perform a
similar function (REF/Aly and viral mRNA binding), however
these regions lack any obvious sequence similarity which would
highlight a common REF-binding motif. Moreover, it was not
known whether ICP27 and ORF57 bind REF in a similar way. A
number of previous studies used deletion mutants of REF to locate
viral binding sites [22,30,31], however in the absence of structural
information at that time, these mutations inadvertently perturbed
the spatial structure of REF. The solution structures of murine Aly
containing only the folded RRM domain [32] and the functional
fragment of REF2-I which contained both the RRM and N-
terminal domains (residues 1–155) have since been determined
and characterised [33]. The REF2-I RRM domain at the surface-
exposed area of a-helices 1 and 2 contains overlapping secondary
binding sites for TAP and UAP56/DDX39; in the free form this
binding site is shielded by loose binding of the N-terminal helix
[33]. Additionally, this RRM has a non-canonical secondary
RNA-binding site comprised of the loop regions [33]. The site of
viral adaptor binding however remained unknown, making it
difficult to understand how the assembly of the viral mRNA-
protein complex is achieved.
Here we apply NMR spectroscopy to explore the binding of
ICP27 and ORF57 with REF at a residue-level resolution and
report a side-by-side comparison of the essential peptide fragments
of ORF57 and ICP27 required for binding with REF. We
demonstrate that the REF recognition site of ICP27 is very short
but highly specific. The atomic resolution structure of REF RRM
domain bound with the fragment of the viral protein adaptor is
presented. The respective REF-binding site on ORF57 is longer
and includes several weaker points of contact. The two viral
proteins however bind at the same site on the REF RRM domain,
which overlaps with the secondary TAP-binding site. The
identified key residues of ORF57 for its interaction with REF
are confirmed by side-directed mutagenesis and ex vivo studies.
Results
Initial identification of binding domains
To confirm the position of REF-binding domains within ICP27
and ORF57 and to minimise the size of constructs for more
detailed NMR mapping, a series of fragments derived from HSV-1
ICP27 were screened for binding to GST-REF2-I using pull down
assays (Fig. 1). The binding of ICP27 aa 1–138 (ICP271–138) was
essentially the same as that of the full-length protein, whereas
ICP271–103 and ICP27139–512 showed no binding (Fig. 1B),
confirming aa 104–138 contain the REF interaction site in vitro,
in agreement with previous studies [19,23]. The GST fusion of
ICP27103–138 was found to interact similarly with full-length
REF1–218, REF1–155 and REF54–155 under the given conditions,
Author Summary
When invading host cells, herpes viruses highjack cellular
components to allow them to replicate. It has been long
recognized that each herpes virus has a specific signature
adaptor protein which, among other functions, inserts viral
mRNA into the cellular mRNA nuclear export pathway,
enabling production of viral proteins by the host cell. This
process has been extensively studied in vivo and in vitro,
but despite many efforts, the molecular and structural
mechanisms of key interactions between viral adaptors
and cellular mRNA export factors have not been described.
Here we present the first atomic-resolution structure of the
key complex between the archetypal viral adaptor ICP27
(from Herpes simplex virus 1) and the cellular mRNA
export factor REF, responsible for introducing viral mRNA
into the cellular nuclear export pathway. We demonstrate
that despite the absence of obvious sequence similarity,
the adaptor protein ORF57 from a different herpes virus
(Herpesvirus saimiri) binds REF in the same site and in a
similar way. We have identified and studied amino acid
residues responsible for REF recognition. Together the
data provide the first molecular insight into how
herpesviral signature proteins recognize cellular proteins,
obtaining access to the cellular mRNA export machinery.
Figure 1. Identification of regions for the interactions between
REF and ICP27/ORF57. (A) Subdivision of ICP27, ORF57 and REF2-I in
fragments. (B) GST-REF pulls down ICP271–138 (NtS) as efficiently as full-
length ICP27, but not ICP271–103 (Nt) and ICP27139–512 (Ct), indicating
that residues 104–138 of ICP27 are involved in REF binding. (C) Fusion
of the ICP27103–138 peptide to GST allows a specific pull down of REF,
REF1–155 (NM) and REF54–155 (D53) and a very weak pull down of the
REF1–70 (N); no interaction is detected with the control Ras protein. (D)
Same pull down assay as panel C but using GST fusion of ORF57 aa 8–
120 in place of ICP27.
doi:10.1371/journal.ppat.1001244.g001
REF Interactions with HSV-1 ICP27 and HVS ORF57
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but only weakly with REF1–70. These data indicate aa 104–138 of
ICP27 are necessary and sufficient for interaction with REF
(Fig. 1C). The REF-binding fragment of ORF57 aa 8–120
identified previously [22] similarly interacted with the same
fragments of REF (Fig. 1D). Unlike an earlier study [22], the
REF54–155 construct used here does not perturb the structure of
the RRM domain [33]. These experiments showed that the main
binding sites for both viral proteins are located within the REF54–155
construct.
To compare the mode of interaction of ICP27 and ORF57 with
REF in more detail, NMR chemical shift mapping of backbone
amides of 15N-labelled REF1–155 and REF54–155 was carried out
(see Supporting Information available online, Fig. S1), by adding
unlabelled ICP271–138 or ORF578–120 (Fig. S2) and monitoring
signal shifts in 1H-15N correlation spectra. The sequence-specific
signal assignment of REF in free form [34] was used to identify
amino acids affected by binding. This indicated that while there
may be a weak transient interaction with the N-terminal region of
REF, especially for ORF57, the main interaction site is located in
the REF RRM domain. The similar pattern of residues showing
changes in chemical shifts induced by ICP27 and ORF57
indicated that both viral proteins bind REF on the same site
(Supporting Information, Fig. S1E). No significant changes were
observed in the 1H-15N correlation spectra of 15N-labelled
REF156–218 upon addition of ICP271–138 or ORF578–120, con-
firming that the REF C-terminal domain is not involved in binding
with these viral protein constructs (Fig. S1F). These initial studies
thus confirm ICP27 and ORF57 bind REF in a similar manner.
Detailed mapping of binding sites
To identify which amino acids of ICP27103–138 and ORF578–120
bind REF54–155, the sequence-specific backbone assignment of free
and bound forms of all these constructs was completed. Titrations
were performed using additions of non-labelled polypeptides to
15N-labelled constructs, while monitoring spectral changes in
1H-15N correlation spectra. ICP27103–138/ORF578–120 was added
to REF54–155, and vice versa. This enabled the mapping of
interaction sites on all proteins at a residue-level resolution. The
values of heteronuclear 15N{1H} NOE were also measured to
identify the parts of polypeptide chains with altered mobility due
to binding (data overview on Fig. 2, with the more detailed data
included in the Supporting Information). Titration of REF with
ICP27103–138 confirmed that this short peptide interacted with
REF in the same manner as the longer ICP271–138 construct, and
also in a similar manner as ORF578–120. The viral protein binding
site on REF RRM was mapped to a-helices 1 and 2 plus the
adjacent loop regions (Fig. 2A and Fig. S3). The converse titration
showed that only a short section of ICP27103–138, namely aa 104–
112, displayed chemical shift changes and decreased mobility,
whereas the rest of the peptide remained flexible in complex
(Fig. 2C and Fig. S4). Similarly, addition of REF54–155 caused
significant changes in signal positions and signal broadening, along
with decreased mobility, primarily within a short section of
residues 103–120 of ORF578–120 (Fig. 2B and Fig. S5), the rest of
the peptide was only weakly affected by binding. The REF-
binding site of ORF57 thus appears to be significantly longer than
that of ICP27, however both viral peptides bind to the same site on
REF (Figs. 3A,B). Unlike the ICP27103–138 -REF54–155 complex, in
the ORF578–120 - REF54–155 complex a number of signals are
broadened beyond detection, indicating that the latter complex is
in the intermediate chemical exchange regime and hence is not
suitable for atomic-resolution structural studies.
Structure of the REF-ICP27 complex
To obtain a detailed view of the ICP27103–138 interaction with
REF54–155 we determined the atomic-resolution structure of this
complex (Fig. 4A–G). The structure of the complex is well-defined
owing to a large number of intra- and inter-molecular NOEs
observed and assigned (Table 1; also Fig. S6). In agreement with the
chemical shift mapping data, the viral peptide binds as a linear
chain along the cleft formed by two a-helices on the surface of the
RRM domain, which largely preserves its structure. However in the
bound state the a-helix 1 of REF is shifted by approximately 3 A˚
(Fig. 4C). This shift causes some rearrangements within the looped
regions, especially aa 136–146. These changes are accompanied by
a noticeable decrease in mobility within the residues 86–90, 93–99,
Figure 2. Identifying interaction sites within REF, ORF57 and ICP27 constructs via different NMR parameters. The detailed data is
presented in SI. Purple solid and broken bars mark residues with large and moderate reduction of mobility upon binding, respectively, as evidenced
by the increase in 15N{1H} NOE. Orange stars mark residues with amide signals broadened beyond detection in the complex. Large and moderate
chemical shift changes (dCS) of amide signals for each ligand as labelled are shown as solid and broken bars, respectively. Red bars mark residues
forming direct inter-molecular NOE contacts in REF-ICP27 complex. (A) Changes in REF54–155 induced by addition of ICP27103–138 and ORF578–120.
Position of secondary structure elements of REF (b-sheets, a-helices and loops) is shown in relation to its sequence. ICP27 and ORF57 bind on the
same site on the REF RRM domain, with a-helices 1 and 2 and adjacent loop regions. (B) Changes in ORF578–120 upon addition of REF54–155. The main
REF-interaction site is mapped to residues 103–120. (C) Changes in ICP27103–138 induced by addition of REF54–155. The REF-binding site is mapped to
residues 104-112.
doi:10.1371/journal.ppat.1001244.g002
REF Interactions with HSV-1 ICP27 and HVS ORF57
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132 and 137–145 as evidenced by 15N{1H} NOE data (Fig 2A).
The shift in a-helix 1 exposes the sidechain of F98 for interaction
with W105 of the peptide, and brings closer the sidechains of a
hydrophobic patch composed of L94, Y135, V138, L140 and M145
(Fig. 4D, E). The upper edge of a-helix 1 contains a negatively
charged patch of D90, E93 and E97 (Fig. 4F). The extended region
aa 104–109 of ICP27 sitting along the REF cleft is followed by a
loose bend at 109–112 which makes additional contacts with REF
and points the remainder of the peptide chain away from the site.
The region aa 114–138 remains flexible and hence does not
participate in binding, in agreement with a lack of intermolecular
NOEs and absence of signal shifts. From a structural perspective,
three ICP27 residues appear most important for the interaction,
forming a recognition triad (Fig. 4E). The sidechain of W105 makes
hydrophobic contacts with F98 of REF and also with the aliphatic
part of the R107 sidechain of ICP27. R107 forms salt bridges with
the acidic residues of REF a-helix 1 (E93 and/or E97, the latter is
the most likely binding partner in light of the decrease in mobility
observed). L108 fits into a hydrophobic pocket composed of REF
residues V86, L94, Y135, V138, L140, M145. Additionally V104
may also play a role in stabilising the complex, by forming
hydrophobic contacts with the aliphatic parts of K130 and K133 of
REF. The sidechain of S106 is solvent exposed and does not appear
to directly bind REF. The ICP27 binding site shows a surprising
degree of complementarity to REF, with a very short sequence used
for highly specific recognition.
Molecular modelling of human Aly-ICP27 complex
Herpes simplex virus (HSV) causes common infections in
humans that occur on the mouth and lips, including cold sores and
fever blisters. Although murine REF2-I protein employed in this
study is commonly used as a model to study mRNA export,
potentially there may be differences in the way ICP27 recognises
its native partner Aly, the human orthologue of murine REF. Here
we explored this issue in detail. A sequence alignment of murine
REF2-I, murine Aly (mAly) and human Aly (hsAly) (Fig. 5A) show
very high level of homology within the RRM domains. Specifically
there are seven amino acid substitutions between murine REF2-I
and human Aly (Fig. 5A). However, only one of these substitutions
lies within a binding site (Fig. 5B and C), namely V138 (which is a
phenylalanine in human Aly). This conservative substitution is
positioned on the periphery of the hydrophobic pocket that
contacts L108 of ICP27. Molecular modelling of the structure of
human Aly bound to ICP27 was performed to see how
significantly the binding interface with ICP27 is affected by the
differences in sequence (Fig. 5D and E). The modelling results
show that the increase in hydrophobic sidechain volume of the
V138F mutation could be readily accommodated by the
movement of the sidechain of M145 (Fig. 5E). All other amino
acid substitutions were positioned away from the binding interface.
Comparison of modelled hsAly-ICP27 and experimental murine
REF-ICP27 solution structure showed a heavy atom backbone
RMSD of only 0.04 A˚, with the architecture of ICP27 binding site
maintained in both homologues. Therefore we conclude that
ICP27 can bind to human Aly in the same manner as to murine
REF2-I.
Exploring the specificity of REF binding site of viral
protein adaptors using synthetic peptides
The characteristic triad, Trp followed shortly by Arg and then
by a hydrophobic residue, is also found in the REF-binding region
of ORF57, and bears distant similarity to the sequences of some
other viral protein adaptors (Table 2 and Fig. S2). To probe the
specificity of recognition, 12 synthetic peptides were tested for
binding with REF54–155 (see Table 2). The first set of peptides was
derived from ICP27 and included WT ICP27103–112 and its three
single point mutants W105A, R107A and L108A, plus a shorter
WT ICP27103–110 peptide with two arginines removed. The
second set was derived from HVS ORF57 and included WT
HVS-ORF57103–120, and its W108A, R111A and V112A mutants,
along with a shortened peptide WT HVS-ORF57105–115 designed
to probe the minimal binding region of ORF57 for REF.
Additionally, two peptides were chosen from other viral proteins
with apparent sequence similarity but containing some variations
in the triad residues, to test how well these can bind REF in our
experiments. We used sequences from Varicella-zoster virus
(VZV) ORF4108–119 (Tyr instead of Trp) and Kaposi’s sarcoma-
associated herpesvirus (KSHV) ORF57100–110 (Tyr instead of Trp,
and Lys instead of Arg). No prior data was available whether this
VZV-ORF4 fragment binds to the RRM domain of REF. For
KSHV-ORF57 a different region was previously implicated in
binding with REF [35,36], therefore the peptide KSHV-
ORF57100–110 was not expected to interact and was used here as
a negative control.
A separate titration of each peptide was carried out under the
same sample conditions. Increasing amounts of peptide were
added to a 15N-REF54–155 sample, achieving binding saturation
whenever possible. Throughout these titrations amide chemical
shift changes were monitored to assess the relative binding affinity
of these peptides for REF and simultaneously map their binding
sites. Estimates of dissociation constants were obtained for each
peptide, and for the longer viral adaptor fragments (Table 2). The
WT ICP27 peptides 103–112 and 103–110 showed very similar
binding characteristics to the longer aa103-138 construct,
Figure 3. Mapping of the ICP27- and ORF57-induced signal
shifts onto the structure of REF RRM domain. Backbone amide
weighted chemical shift changes (dCS) are emphasized by colour. dCS
.0.3 are red, 0.15–0.299 orange, 0.05–0.149 yellow, prolines are blue
and regions unaffected are green. (A) Regions affected by addition of
ICP27103–138. True ICP27 chain position determined based on NOE data
is also shown for reference, with corresponded chemical shift changes
due to REF binding similarly mapped. (B) Similar regions are affected by
ORF578–120 and (C) synthetic peptide ICP27103–103. (D) Synthetic mutant
peptide ICP27103–103 W105A binding affects the same RRM regions,
however the value of shifts at the top of a-helix 1 is reduced,
highlighting the binding site for W105 (encircled on panel C). The
position and numbering of N- and C- terminal residues are indicated.
doi:10.1371/journal.ppat.1001244.g003
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confirming that this peptide comprises the entire binding site (Fig.
S3). The mutant peptide W105A showed reduced affinity to
REF54–155 but still bound with similar chemical shift change
pattern (Fig. 3D and Fig. S3). A reduction in affinity was more
pronounced in the L108A mutant, with the R107A mutation
virtually abolishing the binding. For the HVS peptides,
ORF57103–120 bound with affinity comparable to ORF578–120,
whereas affinity was decreased approximately two orders of
magnitude in the shortened fragment WT-ORF57105–115. This
agrees with the NMR mapping data that a longer sequence from
ORF57 (residues 103–120) is involved in REF binding. The
ORF57 mutant peptides R111A and V112A showed significantly
reduced affinity for REF54–155, whereas the W108A mutant
showed virtually no interaction. The VZV-ORF4108–119 peptide
bound only weakly to REF54–155, whereas the KSHV-ORF57100–110
peptide used here as a negative control did not bind noticeably to
REF (Table 2). These latter two viral adaptors lack the signature Trp
residue, and additionally in KSHV-ORF57 the Arg within the triad is
replaced by Lys. As a further control, we also checked if binding of the
viral peptides is specific to the RRM domain of REF, or if it can occur
with RRMs of other proteins as well. The proteins SF2 [37] and 9G8
[38] bind TAP/p15 and have roles in splicing and mRNA export
Figure 4. Structure of the REF - ICP27 complex. (A) Ribbon representation showing ICP27 coloured blue, and REF RRM coloured green, red and
yellow for looped, a-helical and b-sheet regions, respectively. Positions of N- and C-termini of polypeptide chains are labelled. (B) Overlay of 20 lowest
energy structures with backbone shown in the same orientation, and rotated 180u. The best-fit superposition is made using heavy backbone atoms of
structurally defined regions aa 74–152 of REF and 102–112 of ICP27. Colour-coding is the same as on panel A. (C) Overlay of the RRM domains of free
REF2-I (red, PDB code 2F3J), free murine Aly (purple, PDB code 1NO8) and ICP27-bound REF2-I determined here (green), demonstrating the shift in a-
helix 1 position. (D) Representation of REF – ICP27 complex in the same orientation with partially transparent surface. (E) Schematic of the REF and
ICP27 binding site. ICP27 residues are coloured blue and REF in black; the hydrophobic and electrostatic interactions are indicated by dashes
coloured green and red, respectively. (F) Electrostatic surface with negative and positive charge coloured red and blue, respectively. Bottom row shows
for comparison the known structures of RRM domains (green) with bound peptide ligands (orange). (G) REF54–155 in complex with ICP27103–138,
determined here. (H) UHM domain of human SPF45 in complex with SF3B155-ULM5 (PDB code 2peh, [44]). (I) U2AF35 in complex with U2AF65 (PDB code
1jmt, [42]).
doi:10.1371/journal.ppat.1001244.g004
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somewhat similar to that of REF/Aly. They also contain an RRM
domain and are therefore structurally homologous to REF/Aly. To
test if the same ICP27 motif could interact with these RRM domains,
we added a 5-fold excess of WT ICP27103–112 peptide to 15N-labelled
SF2 [37] and 9G8 [38]. However no significant spectral changes and
hence no binding was observed (Fig. S1). These experiments
confirmed that the recognition of the REF RRM domain by viral
adaptor proteins is highly specific, and the isolated peptides
ICP27103–112, ICP27103–110 and ORF57103–120 are able to bind
REF as efficiently as longer fragments of these viral proteins.
Probing the effect of phosphorylation of ICP27 using an
S114E mutant
Recently it had been suggested that phosphorylation of S114 of
ICP27 [39] may affect its interaction with REF. In the structure
obtained here, this Ser is situated right on the edge of the binding
interface. In order to probe the possible effect of its phosphory-
lation on the interaction with REF, the mutant ICP27103–138
S114E was produced to mimic the presence of the negative charge
on the sidechain. Titration of 15N-labelled REF54–155 with
unlabelled ICP27103–138 S114E revealed binding to the same site
on REF (Fig. S3) and KD estimation showed that the affinity was
only marginally different from the wild type ICP27103–138
construct (Table 2). To determine if the S114E mutation had
any effect on the structure of the ICP27 construct used, we
assigned and compared the fingerprint 1H-15N correlation spectra
of 15N-labelled ICP27103–138 S114E mutant with that of the WT.
The spectra overlaid well for all residues apart from residue 114
itself and its immediate sequential neighbours. According to
15N{1H} NOE measurement, both peptides were flexible in the
free form, hence no structural changes were detected due to
mutation. Titration with unlabeled REF54–155 indicated that the
signals from the same region (aa 104–112) as WT ICP27 are most
perturbed, with only a relatively small signal shift observed for
E114 itself. These data suggest that there are no significant
changes in direct binding of ICP27 to REF RRM in the mutant
which mimics phosphorylation of S114.
Mutations of ORF57 and ICP27 residues identified by
NMR affect binding of human Aly
To confirm the functional significance of critical residues within
the REF binding site identified in ORF57 by chemical shift
mapping experiments and analysis of synthetic peptide binding, a
series of co-immunoprecipitation experiments were carried out
using wild type and mutant forms of GFP-tagged full-length
ORF57 and endogenous Aly in human cells (Fig. 6). Mutants were
chosen that target the candidates for the recognition triad, as well
as selected residues in the binding site and within the vicinity. All
tested mutations within the proposed main binding site caused a
significant decrease in ORF57-Aly affinity (namely, W108A,
double R111A+V112A and R119A+R120A, and also triple
W108A+R111A+V112A mutations, Fig. 6). The double mutants
R79A+V80A and R94A+I95A situated outside the main binding
site caused only a marginal if any decrease in Aly binding. These
data corroborate the chemical shift mapping results and analysis of
binding of synthetic peptide mutants, indicating that the main
REF/Aly interaction site on ORF57 encompass aa 103–120, and
confirms that triad residues W108, R111 and V112 of ORF57, in
addition to R119 and R120, are important for the recognition of
REF/Aly within the context of the functional full-length protein.
Similar co-immunoprecipitation experiments were performed
using wild type and mutant forms of full-length ICP27, specifically
mutating W105A, R107A+L108A and W105A+R107A+L108A.
Results demonstrate that all three mutants showed a significant
reduction in Aly binding, again corroborating data obtained by
chemical shift mapping and analysis of binding of synthetic
peptide mutants (Fig. 7). The co-immunoprecipitation experiments
for both ORF57 and ICP27 confirm that the REF-binding sites
characterized here in detail using shorter polypeptide constructs
are also functionally important for the interaction of these proteins
with Aly/REF in their full-length native forms.
Mutations of HVS ORF57 residues important for REF/Aly
binding affect ORF57-mediated cytoplasmic
accumulation of mRNA
The functional importance of ORF57 residues within REF-
binding site were also measured via an ex vivo assay for cytoplasmic
accumulation of an HVS ORF47 reporter mRNA (Fig. 8), using
wild type and mutant ORF57 proteins, as previously described
[36,40]. As such, the cytoplasmic accumulation detected in this
assay reflects the ability of ORF57 to form an export competent
ribonucleoprotein particle. Human 293T cells were transfected
with pORF47 (a plasmid expressing the late intronless ORF47
mRNA) in the presence of wild type or mutant ORF57 proteins.
After 24 hours RNA was extracted from cytoplasmic fractions and
levels assessed by qRT-PCR. The mutation of residues directly
implicated in the REF/Aly interaction, namely W108A,
Table 1. NMR calculation statistics for an ensemble of the 20
lowest energy structures of REF54–155 bound to ICP27103–138.
Total number of NMR restraints 2500
Number of NOE restraints 2358
Intra-residue 558
Sequential 713
Medium range (2#i#4) 367
Long range intramolecular (5#i) 622
Intermolecular 98
Dihedral 108
Hydrogen bonds 34
Mean number of NOE violations .0.1 A˚ 0.018960.0009
Mean number of dihedral violations .5u 0.799660.1434
Mean Cyana target function, A˚2 6.2060.38
Coordinate precision, A˚
RMSD (REF74–152 + ICP27102–112)
Backbone 0.2560.08
Heavy atom 0.7960.11
RMSD (REF74–152)
Backbone 0.2160.07
Heavy atom 0.7260.08
RMSD (ICP27102–112)
Backbone 0.5560.18
Heavy atom 1.3260.31
Ramachandran plot (REF74–152 + ICP27102-112),
% residues in regions:
Favoured 77.5
Additional 22.2
Generous 0.3
Disallowed 0.0
doi:10.1371/journal.ppat.1001244.t001
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R111A+V112A and R119A+R120A, and also W108A+
R111A+V112A, all substantially reduced the efficiency of the
mRNA cytoplasmic accumulation. In addition, mutations of
residues outside the primary REF-binding site were tested.
Mutation R94A+I95A also similarly reduced cytoplasmic accu-
mulation, whereas R79A+V80A caused only a marginal decrease.
R94 is situated just outside the main REF-binding site and is part
of the nuclear localization signal, and the observed effect can be
possibly explained by its involvement in the interaction with viral
mRNA and/or perturbed nuclear localization. The small effect of
R79 substitution may be due to possible changes in mRNA
binding. The results of these ex vivo experiments confirm the
functional importance of individual residues identified by NMR
for specific binding in the context of native Aly and full-length
ORF57. Moreover, the results suggest that these individual
residues critical for the HVS ORF57 – REF/Aly interaction are
also required to enable efficient cytoplasmic accumulation of viral
mRNA in our assay. This confirms the functional significance of
ORF57 – REF/Aly interaction for ORF57-mediated nuclear
export of viral intronless transcripts, leading to recruitment of
other hTREX proteins [40] and TAP.
Discussion
The use of NMR with short optimised constructs of REF, HSV-
1 ICP27 and HVS ORF57 has allowed the precise determination
of the residues important for the recognition of viral proteins by
the cellular mRNA export factor REF. Despite the lack of obvious
sequence similarity, both viral proteins bind on the same main site,
along the cleft formed by the two a-helices in the RRM domain of
REF. Our data shows that for ICP27 a short but highly specific
amino acid sequence 103–110 is required and sufficient for REF-
binding (with residues 105, 107 and 108 being critical). This region
is immediately followed by a nuclear localization sequence (NLS)
aa110-137 [41], without a significant overlap between the two.
Within the ORF57 protein, the REF-interaction sequence is
significantly longer and includes aa 103–120. The REF interaction
sites of both ICP27 and ORF57 proteins contain a recognisable
Figure 5. Modelling of complex between human Aly and HSV-ICP27. (A) Sequence alignment of RRM domains of murine REF2-I (mREF2-I:
CAB76384) used in this study, murine Aly (mALY: AAC53117) and human Aly (hALY: AAD09608). Position of secondary structure elements (b-sheets, a-
helices and loops) is shown in relation to the REF2-I. Resides in mALY and mREF2-I that differ from hALY are highlighted in light red. (B) A cartoon of
the structure of REF-ICP27 with the position of the 7 amino acid differences indicated using red space-fill spheres, this orientation shown is the same
as used in Fig. 3, whereas in (C) an alternative orientation is used for clarity. Only one amino acid difference is part of the ICP27 interaction site,
namely Val138 of mREF2-I, which is a Phe in hALY. (D) A model of hsALY (blue) overlaid with the experimental structure of mREF2-I (green), with
ICP27 also shown (orange). Residues that differ between the RRM domains of mREF2-I and hsALY are red sticks in the mREF2-I form and cyan sticks in
hsALY. The sidechain of M145 altered in the modelling procedure is indicated by sticks. Also the ICP27 sidechain of L108 is indicated (orange) which is
positioned within the hydrophobic pocket of REF. (E) Detailed view of the sidechains of Met 145, and Val138 and Phe138 in the modelled hsALY
(blue) and experimental REF2-I (green) structures, plus L108 of ICP27 is shown (orange).
doi:10.1371/journal.ppat.1001244.g005
Table 2. Dissociation constants for the interaction of
REF54–155 with viral protein fragments.
Peptide KD (mM) Peptide sequence
ICP27103–138 2868.7 GPLGSVWS-RLGARRPSCS…
ICP27103–138 S114E 1767.9 GPLGSVWS-RLGARRPECS…
ICP27103–110 2567.0 SVWS-RLGA
ICP27103–112 99630 SVWS-RLGARR
ICP27103–112 W105A 5506210 SVAS-RLGARR
ICP27103–112 R107A .10000a SVWS-ALGARR
ICP27103–112 L108A .5000a SVWS-RAGARR
HVS ORF578–120 78612 …SCKTSWADRVREAAAQRR
HVS ORF57103–120 45615 SCKTSWADRVREAAAQRR
HVS ORF57103–120 W108A .7500a SCKTSAADRVREAAAQRR
HVS ORF57103–120 R111A 254650 SCKTSWADAVREAAAQRR
HVS ORF57103–120 V112A 156632 SCKTSWADRAREAAAQRR
HVS ORF57105–115 .1000a KTSWADRVREA
VZV ORF4108–119 .1000a TGYA-RIERGHRR
KSHV ORF57100–110 .100000a NRYGKKIKFGT
Sequences of synthetic and recombinant polypeptides tested here are shown
aligned according to position of triad residues (highlighted bold). Continuation
of amino acid sequence in the construct is indicated as ellipsis. Mutated
residues are underlined.
aEstimate of KD obtained without curve fitting.
doi:10.1371/journal.ppat.1001244.t002
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triad pattern, a Trp shortly followed by an Arg-Leu/Val pair,
which proved to be essential for REF binding. Mutation of these
critical triad residues both in ICP27 and in ORF57 significantly
reduced binding with REF. The insertion of an additional residue
within this triad (as in the case of ORF57) distorts the
complementarity of the binding interface and likely necessitates
the presence of additional compensating contacts (i.e., via R119 and
R120) and hence a longer recognition site. This is supported by
chemical shift mapping, effect of peptide truncation on Kd and a
change in REF binding for the R119,120A double mutant. The
critical REF recognition residues were first identified and
characterized in detail using relatively short protein constructs,
confirming high specificity of detected interactions. It was however
important to show that these REF recognition sites also work in the
full-length native proteins. Here we demonstrate that the mutations
of residues from recognition triads significantly reduced binding
between full-length viral ICP27 and ORF57 and human Aly in co-
immunoprecipitation assays, confirming functional significance of
detected binding sites for proteins in their native form in nearly
physiological conditions, both for ORF57 and ICP27.
The REF recognition site on ICP27 involves residues 103 to 110
(possibly extended to 112) and in our experiments it is entirely
sufficient for highly specific binding with REF in vitro. Based on the
interpretation of in vivo experiments, recently it had been suggested
that phosphorylation of S114 [39] or modifications within the
RNA-binding RGG motif aa 138–152 [27] affect the ICP27
interaction with REF. In the structure presented here, S114 is
positioned very close to the binding site, but not immobilised upon
binding. In principle, one can envisage that phosphorylation of
this residue can make an additional favourable Coulombic contact
with K133 and/or K136 of REF, immobilizing phosphoserine and
strengthening the complex further. We have checked this
Figure 7. Functional importance of triad residues 105, 107 and
108 for the interaction of ICP27 with human Aly. (A) Co-
immunoprecipitation assays were performed on 293T cells transfected
with GFP-tagged ICP27 and its mutants. Mutations probed triad
residues identified in the experimental structure formed between short
protein fragments of ICP27 and REF. Cell lysates were incubated with
Protein A agarose and a polyclonal GFP-specific antibody and
precipitated proteins were analyzed by Western blotting with Aly-
specific antibody and a monoclonal antibody specific to GFP as a
loading control. (B) The relative binding affinities from 3 independent
experiments were analysed quantitatively by densitometry. Point
mutations of the REF recognition triad residues all significantly decrease
binding between full-length ICP27 and endogenous Aly, confirming the
functional significance of these residues identified by NMR.
doi:10.1371/journal.ppat.1001244.g007
Figure 6. Functional importance of the identified REF binding
site for the interaction of ORF57 with human Aly. (A) Co-
immunoprecipitation assays were performed to compare the binding of
wild type ORF57-GFP and ORF57 mutants. Site-directed mutations were
made within the REF binding site of ORF57 and within its vicinity using
Quik-Change II (Stratagene), according to the manufacturer’s instruc-
tions. 293T cells were transfected with GFP-tagged ORF57 and mutant
proteins and after 24 hours cell lysates were incubated with Protein A
agarose and a polyclonal GFP-specific antibody and precipitated
proteins were analysed by Western blotting with Aly-specific antibody
and monoclonal antibodies to GFP as a loading control. (B) The relative
binding affinities in repeated experiments were analysed quantitatively
by densitometry. Point mutations affecting recognition triad residues
108, 111 and 112 and double arginines 119,120 all significantly reduce
ORF57-Aly interaction. Mutations of similar type outside the interaction
site have not affected the interaction between the two proteins.
doi:10.1371/journal.ppat.1001244.g006
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hypothesis here by using a S114E mutant as a phosphoserine
mimic. Both WT-ICP27103–138 and ICP27103–138S114E interact
with REF with similar KD, the mutant interacts only marginally
stronger (Table 2). This insignificant change in affinity observed in
our experiments and the position at the periphery of the REF-
binding motif suggests that it is unlikely that modifications of S114
can provide a direct stringent control of the REF-ICP27
interaction. This agrees with the observation that the S114A
mutant still co-immunoprecipitates with REF/Aly [39]. Similarly,
the RNA-binding RGG motif (aa 138–152) is positioned
sequentially away from the specific REF-binding motif. Modifica-
tions in this RGG motif are unlikely to have a direct effect on
ICP27-REF binding. The effects of ICP27 modifications outside
the main 103–110 site on REF binding recently observed in vivo
[27,39] can be alternatively explained by trapping the mutated
ICP27 in complexes upstream of the pathway, as suggested by
[39]. Additionally, modifications within the RGG region of ICP27
may affect binding with RNA; this could indirectly affect ICP27-
REF affinity if the RNA bridges the two proteins. Further
experiments, which take into account cellular availability of
modified ICP27 for interaction with REF/Aly and the bridging
role of mRNA, are needed to reconcile the in vivo and in vitro data.
Here we have presented the first atomic-resolution structure of
the complex between the fragment of archetype viral signature
protein, ICP27, and the cellular export factor REF2-I. The ICP27
peptide binds on the a-helical side of the RRM domain, along the
crevice between a-helices. The position of this peptide is defined
by the presence of multiple unambiguous NOE contacts, which in
particular pinpoint the position of the W105 and L108 of ICP27
(Fig. S6D and Fig. S7) and therefore align the peptide along the
crevice. The corresponding 3D structure of human Aly bound to
ICP27 is currently unknown, but within the ICP27 binding site the
two proteins differ by just one amino acid residue in position 138,
with Phe for Aly and Val for REF2-I. This site is situated on the
periphery of the hydrophobic patch which interacts with L108 of
ICP27 (Fig. 5). Comparative modelling of human Aly suggested
the mutation could be easily accommodated without disrupting
the interaction, therefore the complex between human Aly and
ICP27 is likely to be structurally very similar to the one between
REF2-I and ICP27 determined here. This modelling provides a
molecular level insight into how the ICP27 protein from Herpes
Simplex virus may interact with human Aly, to facilitate the
nuclear export of herpesviral intronless mRNA, an essential
prerequisite for virus replication.
The previous examples of peptides bound on the a-helical side
of RRM-type domains differ from the structure described here.
The U2AF homology motifs (UHM) have been shown to
recognize a Trp residue which is preceded by a stretch of basic
residues [42–44]. In the UHM-type of recognition, the signature
Trp sidechain of the peptide is inserted into the hydrophobic
pocket formed mainly by the looped regions, with the bound
peptide running almost perpendicular to the crevice between the
two a-helices (Fig. 4H,I). The characteristic Arg-X-Phe motif
situated in the loop shortly after a-helix 2 is the defining signature
of UHMs and is the key to Trp recognition [43]. The RRM of
REF2-I clearly lacks this motif, and therefore does not belong to
UHM class. Moreover, the similar hydrophobic pocket in the REF
RRM is occupied by Leu108 of ICP27, and not by Trp (Fig. 4G–
I). Interestingly, the presence of the Trp appears not to be as
crucial as the other triad residues involved in ICP27 recognition,
as its mutation reduces binding only one order of magnitude
(Table 2). Residues more important for ICP27 binding are Arg107
and Leu108. Unlike in UHM recognition, in the REF - ICP27
complex the Trp makes contacts mainly with the top of a-helix 1,
and middle part of a-helix 2. Both the abundant NOE contacts
(Figs. S6 and S7) and relative perturbations caused by the W105A
mutation (Fig. 3C,D), all consistently indicate that the mode of
ICP27 binding with REF is different from peptide recognition by
UHMs. Recently another apparently similar complex between
PTB-RRM2 and Raver1 peptide has been described by NMR and
modelling [45], where a crucial Leu-Leu pair of the LLGxxP motif
is inserted in the binding pocket in the loops adjacent to a-helix 2.
In this modelled complex the peptide also has a different
orientation, compared with our structure based on direct NOE
restraints, and interacting motifs have little similarity. Therefore,
the structure presented here displays another, previously unde-
scribed, mode of peptide-RRM recognition, adding to the
previously recognized diversity of RRM-ligand interactions [46].
Previously, the position of viral mRNA binding sites on ORF57
has been loosely mapped to aa8-120 [22,28,29]. As the REF
binding site aa103-120 is situated within the same fragment, it is not
clear yet whether RNA and REF/Aly binding to ORF57 occurs
concurrently or cooperatively. Our further studies are aimed at
clarifying this. In the case of ICP27, the viral mRNA binding site is
situated within the RGG region shortly following the REF-binding
site. One can therefore anticipate that ICP27 brings and introduces
the viral mRNA to REF/Aly, which can bind both ICP27 (via
RRM domain) and viral mRNA (via N- and C-termini) simulta-
neously, ensuring a multi-contact interaction interface.
Here we demonstrated that point mutants in positions 108, 111,
112, 119 and 120 that reduce the ORF57 - REF/Aly interaction
also dramatically decrease the ability of ORF57 to promote the
nuclear export of intronless viral mRNA. Therefore these residues
are functionally important for mRNA export, likely by directly
mediating recruitment of REF/Aly. The ability of ORF57 and
homologues to interact with export adapter proteins, such as
REF/Aly, and possibly functional homologues such as UIF [13], is
therefore likely to be essential for the formation of an export
competent ribonucleoprotein particle. This in turn is essential for
efficient viral mRNA nuclear export and subsequent virus
Figure 8. Perturbing the ORF57-REF/Aly interaction with point
mutations decreases cytoplasmic accumulation of viral mRNA.
293T cells were transfected with the pORF47 reporter mRNA construct
and the vectors containing wild type ORF57 or its mutants, and RNA
was isolated from cytoplasmic fractions. The mutations probed residues
from REF binding site, as well as from its vicinity. qRT-PCR was
performed and data for mRNA reporter plus ORF57-transfected cells
normalised against cells transfected with reporter in the presence of
GFP. A DDcT method was applied to determine the relative levels of
reporter mRNA between samples. Point mutations of ORF57 residues
implicated in direct interaction with REF, and reducing its binding, all
caused significant decrease in cytoplasmic accumulation of viral mRNA.
doi:10.1371/journal.ppat.1001244.g008
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replication, as we have previously demonstrated that recruitment
of the complete hTREX complex to viral intronless mRNAs is
essential for both HVS and KSHV lytic virus replication [29,35].
Similarly, mutations of ICP27 residues in positions 105, 107 and
108 have also been shown here to decrease the interaction
between full-length ICP27 and human Aly. Further experiments
are needed to confirm the effect of mutations of recognition triad
residues on the viral mRNA export mediated by ICP27. The
functional role of the REF/Aly binding regions in ICP27 export to
the cytoplasm have been studied previously by deletion of
polypeptide fragments. Specifically, ICP27 deletions 64–108 (d2-
3) and 109–138 (d3-4) were used and interpreted as mutants
perturbing interaction with REF/Aly [17]. The current work
suggests that in fact only the first of these two deletions affected the
REF/Aly recognition triad. In the second d3-4 construct the main
REF/Aly binding site was completely preserved, while the NLS
was perturbed. This may explain why the d3-4 mutant maintained
efficient export of ICP27 to the cytoplasm [17] – the interaction of
this construct with REF/Aly was in reality possible. Moreover, the
deletion constructs said to be lacking the REF/Aly binding site
and used to demonstrate the absence of REF/Aly bridging
between ICP27 and TAP/NXF1 [17], in fact, inadvertently
preserved this site. In view of the detailed data presented here on
the exact point mutations (residues 105, 107 and 108) which will
perturb interactions with REF/Aly without affecting the NLS
aa110-137, further functional studies may be warranted to
reconsider the suggested diminished roles of the ICP27 - REF/
Aly interaction in cytoplasmic export of ICP27, and of REF/Aly
in mediating interactions with TAP/NXF1 [17]. Such studies
however should consider the possibility that other adaptor proteins
[12–14] may substitute the function of REF/Aly in vivo once the
ICP27 – REF/Aly interaction is blocked, complicating the
analysis. Additional experiments are also required to assess and
map interaction of ICP27 with functional homologues of REF/Aly
such as the recently identified UIF protein [13], to explore the role
of alternative pathways. Regardless of how essential the REF-viral
protein interaction appears from siRNA evidence [14], the
recruitment of the ubiquitously-present cellular export factor
Aly/REF to viral ICP27/ORF57 can be envisaged as a highly
useful pathway linkage, increasing an overall efficiency of viral
mRNA export, due to the ability of this export factor to remodel
TAP triggering high affinity RNA - TAP interactions [10]. The
main interaction site for TAP on REF is an N-terminal arginine
rich motif; however, the REF RRM also contributes to TAP
interactions [10,33] and this secondary site overlaps with the site
recognised by ICP27 and ORF57. Therefore TAP recruitment is
likely to lead to remodelling of the viral ribonucleoprotein
complex. Although the partial displacement of the viral adaptor
fragment from the surface of RRM of REF upon TAP binding
may be possible, the complete displacement of the viral proteins
from the ribonucleoprotein complex seems unlikely since a ternary
complex of REF - TAP and ORF57/ICP27 assembles in vitro
[19,22]. Further studies are required to establish how the viral
mRNA export complex is remodelled during export and which
proteins contact the viral mRNA directly at each point in the
export pathway.
Materials and Methods
Protein expression and purification
Constructs REF1–155, REF54–155, ICP271–138 and ORF578–120,
expressed in pET24b (Novagen) vector, were produced as described
previously [33], with additional purification on a Superdex 75 (GE
Healthcare) column (GF buffer: 20 mM phosphate, 150 mM NaCl,
50 mM L-Arg/L-Glu/b-mercaptoethanol and 10 mM EDTA,
pH 6.2). Proteins SF2 and 9G8 were purified as described previously
[37,38]. ICP27103–138 WT and S114E peptides were expressed as
GST-fusions in a pGEX-6P-1 plasmid, and cleaved by PreScission
protease on GSH resin according to standard protocol (GE
Healthcare). Eluted peptide was supplemented with 5 mM DTT
and protease inhibitor cocktail (Roche), and exchanged into GF
buffer using an Amicon pressure cell with 1 k MWCO membrane via
a series of dilutions/concentrations. A Sephacryl S-100 HR (GE
Healthcare) gel filtration column was used to purify the peptide
further. Peptide was .95% pure according to tricine-SDS-PAGE.
Pull down assays and co-immunoprecipitations
GST or GST protein fusions were first immobilised on 30 ml
slurry glutathione-coated beads (GE Healthcare) before 8 ml 35S-
radiolabelled proteins synthesised in rabbit reticulocytes (Promega)
were added to the binding reactions in RB100 buffer (25 mM
HEPES pH 7.5/100 mM KOAc/10 mM MgCl2/1 mM DTT/
0.05% Triton X-100/10% glycerol) in presence of 10 mg/ml
RNAse A. Washed and eluted protein complexes were resolved on
15% SDS-PAGE stained with Coomassie blue and analysed by
PhosphoImage. To analyse the effect of HVS ORF57 and HSV-1
ICP27 point mutations on Aly/REF binding, co-immunoprecipi-
tation were performed as previously described [47,48]. Human
293T cells were transfected with wild type GFP-ORF57 or GFP-
ICP27 and respective mutants, generated using the QuickChange II
site-directed mutagenesis kit (Stratagene), using Lipofectamine 2000
(Invitrogen, Paisley, UK), as per the manufacturer’s instructions.
Briefly, after 24 hours, cell lysates were harvested, precleared with
Protein A agarose for 1 hour at 4uC and then incubated with
polyclonal GFP-specific antibody for 2 hours at 4uC. Protein A
agarose was added to the cell lysates and incubated for a further
3 hours at 4uC. The agarose was washed 3 times to remove
unbound protein. Western blot analysis was then performed using
an Aly-specific antibody and GFP-specific monoclonal antibody as a
loading control. Densitometry analysis was then performed on 3
independent experiments using the ImageJ software.
Cytoplasmic mRNA accumulation assay
293T cells were transfected with ORF57 or the respective mutants
in the presence of the pORF47 reporter mRNA as previously
described [49]. Cytoplasmic ORF47 mRNA levels were then assessed
by qRT-PCR as previously described [36]. Briefly, after 24 hours,
cells were lysed in 200 ml of PBS 1% Triton-X 100 (v/v) containing
40 U of RNAse Out (Invitrogen), and cytoplasmic fractions isolated
using Trizol (Invitrogen) as previously described [36]. Total RNA
(1 mg) from each fraction was reverse transcribed using Superscript II
(Invitrogen) and 10 ng of cDNA used as template in SensiMixPlus
SYBR qRT-PCR reactions (Quantace). qPCR was performed using
the Rotor-Gene Q 5plex HRM Platform (Qiagen), with a standard 3-
step melt program (95uC melt for 30 sec, 60uC annealing for 15 secs,
72uC extension for 20 secs). Following confirmation that qPCR
efficiency was comparative between ORF47 and the reference
mRNA (GAPDH), quantitative analysis was performed using DDcT
analysis as previously described [36].
NMR experiments
All experiments were carried out at 30uC on Bruker DRX600,
DRX700 and Varian Inova 800 MHz spectrometers equipped
with cryoprobes. The weighted chemical shift changes of amide
signals dCS caused by complex formation were measured as
dCS~
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
DdH
 2
z DdN
 
=10
 2q
, where DdH and DdN were
changes in proton and nitrogen chemical shifts, respectively.
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Standard triple-resonance experiments were used to assign spectra
of ICP27103–138, ORF578–120 and REF54–155 in their free and
bound states. Additionally, carbon-detection experiments (CON,
CaCO, CbCaCO, CbCaCO(N), CbCaNCO) were used as an aid
to the ORF57 assignment. Spectra were processed using
NMRpipe [50] and Topspin 2.1 (Bruker) and analysed using
Sparky (University of California). Distance restraints obtained
from 3D 15N- and 13C edited NOESY-HSQC experiments (tm
120 ms) and dihedral restraints from TALOS [51] were used in
structure calculations by CYANA [52]. Additionally, intermolec-
ular contacts were unambiguously identified using 13C edited, 12C-
filtered NOESY-HSQC (tm 150 ms) spectra acquired on Varian
Inova 800 MHz spectrometer. In this experiment only NOE
crosspeaks between 1H-13C moieties of 13C,15N-labelled REF and
1H(12C) of unlabelled ICP27 peptide were observed [53,54]. A
final ensemble contained 20 structures with lowest target function
values. Images were generated using Pymol (DeLano Scientific).
For the REF - ICP27 complex, structure coordinates and
experimental constraints have been deposited into the Protein
Data Bank and chemical shifts in the BioMagResBank (access
numbers 2kt5 and bmr16683 respectively). Other chemical shift
assignments deposited in the BioMagResBank are: free ICP27103–138
bmr16696, free REF54–155 bmr16697, and ORF578–120 bmr16698
(both free and bound to REF54–155).
Unlabelled synthetic peptides were obtained from Peptide
Protein Research Ltd (UK). The synthetic peptide sequences used
were from Varicella-zoster virus ORF4108–119 (AAY57694),
Kaposi’s sarcoma-associated herpesvirus ORF57100–110
(YP_001129410), Herpesvirus Saimiri ORF57103–120 & 105–115
(CAC84353), Herpes simplex virus 1 ICP27103–110 & 103–112
(AAF43147). Dissociation constants (KD) were derived by moni-
toring chemical shift changes in 1H-15N correlation spectra of
100 mM 15N-REF54–155 as a function of increasing peptide
concentrations, and fitting data to the standard equation [55].
For very weak binding peptides where chemical shift changes were
too small to obtain a curve for fitting, a lower limit estimate of KD
was obtained by comparisons of the magnitude of chemical shift
change observed relative to those of stronger complexes.
Molecular modeling
Comparative modelling of the human Aly – ICP27 complex was
performed using Swiss-PdbViewer [56] and the lowest energy
conformer of the REF - ICP27 complex as a template. Mutations
A75G, D107H, D119N, R125K, K136N, V138F and D146N
(which reflect the differences between murine REF2-I and human
Aly within the RRM domain) were introduced. All mutations
except V138F involved solvent exposed sites and did not cause
steric clashes. For the V138F substitution, a conformation was
chosen that minimised the number of steric clashes while
orientating the aromatic sidechain towards the hydrophobic core
of REF. An energy minimization was conducted to remove the
remaining steric clash with the e-methyl of M145, resulting in a
change in the M145 side chain rotamer, and virtually no
movement of the backbone (heavy atom backbone RMSD of
0.04 A˚).
Supporting Information
Figure S1 Overall identification of amino acid residues of
REF2-I affected by binding with viral protein fragments plus SF2
and 9G8 spectra. Chemical shift changes within REF spectra were
monitored upon addition of ICP27 or ORF57 constructs as an
indication to which amino acids are involved in binding. Where
the weighted chemical shift changes of amide signals dCS caused
by complex formation were above 0.1, or the peak could not be
followed due to broadening, an arrow is drawn. REF1–155
was titrated with ORF578–120 (A) and ICP271–138 (B), similarly
REF54–155 was titrated with ORF578–120 (C) and ICP271–138 (D).
Mapping of residues affected by binding is demonstrated (E). From
the same titration data, ribbon representation of REF (i) is shown
in the same orientation as surface representations showing charge
(ii) with acidic and basic residues colored red and blue. Chemical
shift changes from ORF57 (iv and vi) and ICP27 (iii and v)
titrations are mapped with significant changes colored red. Labels
used: NM, REF1–155; D53N, REF54–155. The similar pattern of
shift changes throughout supports both ICP27 and ORF57 have
the same main binging site situated in the folded RRM domain of
REF. The changes to the chemical shifts within N-helix are likely
to be caused by the release of N-helix which is normally bound to
the same site in the free state of the protein [33]. (F) Overlay of
15N-HSQC spectra of the C-terminal region (residues 156–218) of
REF2-I show no significantly changes from free form (red) upon
addition of 2-fold excess of either ICP271–138 (blue) or ORF578–120
(green). Signals marked with asterisks originate from residues of C-
terminal His-tag which are not part of REF. Additionally, 15N-
HSQC spectra of the RRM domains of both 9G8 (G) and SF2 (H)
show no changes upon addition of 2-fold excess of ICP27103–112
synthetic peptide.
Found at: doi:10.1371/journal.ppat.1001244.s001 (3.88 MB TIF)
Figure S2 Sequence alignment of N-terminal parts of ICP27
homologues from a and c herpesviruses. The first 200 amino acids
of HSV-1 ICP27 (AAF43147) containing the REF-interaction site
was aligned manually with the predicted unstructured N-terminal
regions of the proteins HSV-2 UL54 (NP_044525), EBV EB2
(YP_401659), HVS ORF57 (AAA46125), KSHV ORF57
(YP_001129410) and VZV ORF4 (NP_040127). REF-interacting
regions identified in this study are shown in bold, and regions
probed for REF-binding using synthetic peptides are underlined.
There is very weak homology between export adaptors within the
N-terminal regions shown, with the exception of the very closely
related HSV-1 ICP27 and HSV-2 UL54 proteins.
Found at: doi:10.1371/journal.ppat.1001244.s002 (0.34 MB TIF)
Figure S3 More detailed analysis of REF54–155 interactions with
viral protein fragments and their mutants using NMR spectros-
copy. (A) Amino acid sequence of REF construct (shown in a
zigzag fashion), with T7 and poly-His tags coloured blue.
Secondary structure elements are indicated with helices as red
blocks, sheets as yellow arrows and larger loops as dotted lines. (B)
Chemical shift changes dCS in backbone amides of REF54–155
upon addition of peptides: ICP27103–138, green circles & dashed
line; ORF578–120, blue circles & dotted line; ICP271–138, purple
diagonal crosses; ICP27103–112 synthetic peptide, red squares;
ICP27103–112 W105A synthetic peptide, yellow plus signs;
ICP27103–138 S114E synthetic peptide, green triangles. All the
peptides were added in a 5-fold molar excess with respect to REF.
(C) Heteronuclear 15N [1H] NOEs measured for REF54–155 in
absence (red circles) and presence (green triangles) of ICP27103–138
were used as a measure of mobility change upon binding. (D)
Overlay of 1H-15N-correlation HSQC spectra of REF54–155 with
increasing amounts of ICP27103–138 added. Signal assignment is
shown. Spectra are coloured red though green for free to bound
forms of REF, respectively. Spectra are shown for the ratios 1:0,
1:0.5, 1:1, 1:1.5 and 1:2 (REF:ICP27). (E) Comparison of TROSY
spectra of REF54–155 in free form (red), bound to ICP27103–138
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(green), bound to ORF578–120 (blue) suggests that the binding of
ICP27 and ORF57 fragments affects essentially the same signals
and hence occurs at the same binding site. All NMR experi-
ments were carried out in the same NMR buffer (20 mM
phosphate, 50 mM NaCl, 50 mM L-Arg/L-Glu/b-mercaptoeth-
anol and 10 mM EDTA, pH 6.2 plus 10 mM DTT and 0.1%
NaN3).
Found at: doi:10.1371/journal.ppat.1001244.s003 (1.79 MB TIF)
Figure S4 Analysis of ICP27103–138 interactions with REF54–155
using NMR spectroscopy. (A) Amino acid sequence of ICP27
construct. The sequence from the remaining PreScission protease
cleavage site is coloured blue. (B) Chemical shift changes in
backbone amides of ICP27103–138 upon addition of Ref54–155, red
squares. The horizontal dashed lines represent thresholds for strong
and medium shift changes used for creating the summary Fig. 2. (C)
Heteronuclear 15N [1H] NOEs measured for ICP27103–138 in free
form (green circles) and in presence of REF54–155 (red squares) were
used to detect the change in polypeptide mobility. (D) Overlay of
1H-15N-correlation HSQC spectra of wild type ICP27103–138 (blue)
with ICP27103–138S114E (red) in free form and ICP27103–138S114E
with a 5-fold excess of REF54–155 added (green). The inset at the top
right shows indole region of the spectrum. (E) Overlay of 1H-15N-
correlation HSQC spectra of ICP27103–138 with various amounts of
added REF54–155. Labels show sequence-specific signal assignment.
Spectra are coloured blue (through green) to red for the free and
complexed peptide respectively. For clarity only the 1:0, 1:0.25,
1:0.5, 1:0.75, 1:2, and 1:6 (ICP27:REF) spectra are shown. (F)
Comparison of 15N-HSQC spectra of ICP27103–138 peptide in free
(blue) and REF54–155 bound form (red) and ICP271–138 in free (cyan)
and REF54–155 bound form (orange). Assignments for bound form of
ICP27103–138 are shown. The spectrum of ICP27103–138 overlays
well with the spectrum of ICP271–138, this suggests that the
truncation does not disrupt the structure of the shorter construct.
The REF-binding site of ICP27 1–138 is all situated within the 103–
138 fragment, as signals from other parts of this longer viral protein
construct are not affected by binding with REF.
Found at: doi:10.1371/journal.ppat.1001244.s004 (1.42 MB TIF)
Figure S5 Analysis of ORF578–120 interactions with REF54–155
using NMR spectroscopy. (A) Amino acid sequence of ORF57
construct, with T7 and poly-His tags coloured blue. (B) Chemical
shift changes in backbone amides of ORF578–120 upon addition of
REF54–155 are shown as red triangles. The arrows identify residues
broadened beyond detection in the bound state. The horizontal
dashed lines represent thresholds for strong and medium shift
changes used for creating the summary Fig. 2. (C) 15N [1H] NOEs
measured for ORF578–120 in free form (black crosses) and in
presence of REF54–155 (red squares) identify regions with
polypeptide mobility changed upon binding. Orange stars mark
residues with amide signals broadened beyond detection in the
complex, for these no NOE data could be obtained. (D) Overlay of
15N-HSQC spectra for titration of ORF578–120 with REF54–155.
Spectral assignment is shown. Spectra are coloured orange though
blue for free to bound forms of REF respectively. Spectra are
shown for the ratios 1:0, 1:0.15, 1:0.3, 1:1, 1:3 and 1:6
(REF:ORF57). A relatively small number of signals are affected
by binding. REF-binding site of ORF57 is short and comprises
residues 103–120.
Found at: doi:10.1371/journal.ppat.1001244.s005 (1.45 MB TIF)
Figure S6 NOE derived distance constraints used in the
structure calculation of the REF54–155 and ICP27103–138 complex.
The position of short and medium range NOE d-connectivities are
shown in (A) for REF and (B) for ICP27, the protein sequence
coloured blue highlights tags introduced in cloning. (C) The
distribution of all NOEs on a per residue basis. White, light grey,
dark grey and black shading of bars indicates the number of
meaningful intra-residue, sequential (i+1), medium (2#i#4) and
long (5#i) range constraints. Two samples were used for structure
determination of the ICP27103–138:REF54–155 complex, these
contained one protein 13C/15N uniformly labelled at 1 mM plus
the binding partner in unlabelled form at 2 mM. Small over-
titration of the labelled component was necessary to observe the
signals otherwise broadened in the equimolar complex. (D)
Intermolecular NOE restrains used in structure calculations are
shown schematically between the individual residues of REF and
ICP27. Positions of two a-helices of REF are marked. Each line
corresponds to a non-redundant NOE restraint. Dark green
continuous lines represent NOEs obtained unambiguously from
13C edited, 12C-filtered NOESY-HSQC spectra. Additional NOEs
represented by light green dashed lines were obtained from more
sensitive standard 3D NOESY-HSQC spectra.
Found at: doi:10.1371/journal.ppat.1001244.s006 (1.15 MB TIF)
Figure S7 Example sections of 3D 13C edited, 12C-filtered
NOESY-HSQC spectra showing intermolecular NOEs. Positive
signals are coloured red and negative green. ICP27 1H signal
assignments are shown in blue (horizontal dashed lines and marks)
and REF 1H assignments shown as vertical orange dashed lines.
The experiment selects NOE cross peaks between 1H(12C) of
unlabelled ICP27103–138 and 1H-13C moieties of 13C,15N-labelled
REF54–155, therefore providing exclusively inter-molecular
restraints.
Found at: doi:10.1371/journal.ppat.1001244.s007 (0.87 MB TIF)
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